Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: Final results of a phase II study (ESTER-1)

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 6, 2010, Pages 577-582

  MacChia, Gabriella ^a   Ferrandina, Gabriella ^a,b   Legge, Francesco ^a   Deodato, Francesco ^a   Ruggieri, Valeria ^a   Lorusso, Domenica ^b   Padula, Gilbert D A ^c   Valentini, Vincenzo ^b   Cellini, Numa ^b   Scambia, Giovanni ^b   Morganti, Alessio G ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c Saint Mary's Health Care   (United States)

Author keywords

Chemotherapy; Combined modality treatments; Preoperative radiotherapy; Uterine cervix carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; FEMALE; FIBROSIS; GASTROINTESTINAL TOXICITY; HUMAN; LEG EDEMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRESCRIPTION; RADIATION DOSE; SKIN TOXICITY; TREATMENT RESPONSE; TUMOR VOLUME; URINE RETENTION; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 78650005083     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181b9cf5c     Document Type: Article

References (30)

1. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet. 2001;358:781-786.
2. Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer-a meta-analysis. Clin Oncol (R Coll Radiol). 2002;14:203-212.
3. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
4. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New Eng J Med. 1999;340:1137-1143.
5. Whitney CW, Sauser W, Bundy BN, et al; Gynecologic Oncology Group and Southwest Oncology Group study. Randomized comparison of fluorouracil plus cisplatin vesus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol. 1999;17:1339-1148.
6. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Eng J Med. 1999;340:1144-1153.
7. Resbeut M, Cowen D, Viens P, et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol. 1994;54:68-75. (Pubitemid 24239411)
8. Jurado M, Martínez-Monge R, López-García G, et al. Chemoradiation followed by surgery: its role in local control in advanced cervical cancer. Rays. 1998;23:508-521.
9. Jurado M, Martínez-Monge R, García-Foncillas J, et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery + intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol. 1999;74:30-37.
10. Mancuso S, Smaniotto D, Benedetti Panici P, et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol. 2000;78:324-328.
11. Distefano M, Ferrandina G, Smaniotto D, et al. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility. Oncology. 2004;67:103-111.
12. Classe JM, Rauch P, Rodier JF, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006;102:523-529.
13. Distefano M, Fagotti A, Ferrandina G, et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol. 2005;99(3 suppl 1):S166-S170.
14. Houvenaeghel G, Lelievre L, Gonzague-Casabianca L, et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol. 2006;100:338-343.
15. Ferrandina G, Legge F, Fagotti A, et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecol Oncol. 2007;107(1 suppl 1):S127-S132.
16. Simon R. Optimal two stage design for phase II clinical trials. Control Clin Trials. 1989;10:1-10.
17. Capirci C, Polico C, Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using new "up down table" device. Int J Radiat Oncol Biol Phys. 2001;51:465-473.
18. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44:265-272.
19. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
20. Chassagne D, Sismondi P, Horiot JC, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol. 1993;26: 195-202.
21. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216. (Pubitemid 30099779)
22. Kaplan FL, Meier P. Nonparametric estimation from incomplete observations. Am J Stat Assoc. 1958;53:457-481.
23. Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc. 1972;135:185-207.
24. Perez CA, Grigsby PW, Castro-Vita H, et al. Carcinoma of the uterine cervix: part I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;32:1275-1288.
25. Chen SW, Liang JA, Yang SN, et al. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol. 2003;67:69-76.
26. Cellini N, Smaniotto D, Scambia G, et al. Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: A dose-escalation study. Am J Clin Oncol. 2008;31:280-284.
27. Lerouge D, Touboul E, Lefranc JP, et al. Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion. Cancer Radiother. 2004;8:168-177.
28. Bernard A, Touboul E, Lefranc JP, et al. Epidermoid carcinoma of the uterine cervix at operable bulky stages IB and II treated with combined primary radiation therapy and surgery. Cancer Radiother. 2002;6:85-98.
29. Azria E, Morice P, Haie-Meder C, et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol. 2005;12:332-337.
30. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol. 1995;35:83-90.